These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2788981)

  • 61. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus.
    Grunow R; Jahn S; Porstmann T; Kiessig SS; Steinkellner H; Steindl F; Mattanovich D; Gürtler L; Deinhardt F; Katinger H
    J Immunol Methods; 1988 Feb; 106(2):257-65. PubMed ID: 2828478
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human hybridoma generation by hypo-osmolar electrofusion: characterization of human monoclonal antibodies to Schistosoma mansoni parasite antigens.
    Klock G; Wisnewski AV; el-Bassiouni EA; Ramadan MI; Gessner P; Zimmermann U; Kresina TF
    Hybridoma; 1992 Aug; 11(4):469-81. PubMed ID: 1398684
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antibody producing human-human hybridomas. I. Technical aspects.
    Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
    J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas.
    Karsten U; Stolley P; Walther I; Papsdorf G; Weber S; Conrad K; Pasternak L; Kopp J
    Hybridoma; 1988 Dec; 7(6):627-33. PubMed ID: 3235098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The establishment of human anti-tetanus toxoid hybridomas with in vitro immunized human tonsil cells].
    Jiang ZQ; Sun PF; Ji YY; Yeh M; Kuroda K; Kamei M; Hashizume S
    Shi Yan Sheng Wu Xue Bao; 1992 Sep; 25(3):237-42. PubMed ID: 1476015
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improvement in the basic technology of electrofusion for generation of antibody-producing hybridomas.
    Ohnishi K; Chiba J; Goto Y; Tokunaga T
    J Immunol Methods; 1987 Jun; 100(1-2):181-9. PubMed ID: 3110294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficient generation of stable antibody forming hybridoma cells by electrofusion.
    Schmitt JJ; Zimmermann U; Neil GA
    Hybridoma; 1989 Feb; 8(1):107-15. PubMed ID: 2925206
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhanced hybridoma production by electrofusion in strongly hypo-osmolar solutions.
    Schmitt JJ; Zimmermann U
    Biochim Biophys Acta; 1989 Jul; 983(1):42-50. PubMed ID: 2758049
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Establishment of hybridoma secreting anti-mycobacteria monoclonal antibody by using electrofusion technique].
    Guo M; Pan Z; Wang H
    Wei Sheng Wu Xue Bao; 1998 Oct; 38(5):393-5. PubMed ID: 12549406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of human hybridomas secreting antibody to tetanus toxoid.
    Larrick JW; Truitt KE; Raubitschek AA; Senyk G; Wang JC
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6376-80. PubMed ID: 6578513
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Estimation of heterokaryon formation and hybridoma growth in murine and human cell fusions.
    Alkan SS; Mestel F; Jiricka J; Blaser K
    Hybridoma; 1987 Aug; 6(4):371-9. PubMed ID: 3623581
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New strategies to establish human monoclonal antibodies.
    Kudo T; Saeki H; Saijyo S; Sato N; Numasaki M; Tachibana T
    Tohoku J Exp Med; 1992 Oct; 168(2):323-7. PubMed ID: 1306317
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion.
    Schmidt E; Leinfelder U; Gessner P; Zillikens D; Bröcker EB; Zimmermann U
    J Immunol Methods; 2001 Sep; 255(1-2):93-102. PubMed ID: 11470290
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Facilitated cell fusion for hybridoma production.
    Conrad MK; Lo MM
    Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
    [No Abstract]   [Full Text] [Related]  

  • 76. Production and purification of monoclonal antibodies.
    Nakazawa M; Mukumoto M; Miyatake K
    Methods Mol Biol; 2010; 657():75-91. PubMed ID: 20602208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic engineering of human lymphocytes for the production of monoclonal antibodies.
    Mally MI
    Hum Antibodies Hybridomas; 1990; 1(1):27-33. PubMed ID: 1966472
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An extreme strategy for the production of hybridoma.
    Golestani R; Pourfathollah AA; Moazzeni SM
    Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Production of stable human-mouse hybridomas secreting monoclonal antibodies against Rh D and c antigens.
    Rapaille A; François-Gérard C; Donnay D; Sondag-Thull D
    Vox Sang; 1993; 64(3):161-6. PubMed ID: 8484248
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increasing hybridoma viability and antibody repertoire after the cell fusion by the use of human plasma as an alternative supplement.
    Lee RJ; Wu JS; Juang RH; Wu YJ; Lin CY; Wu SY; Huang PR; Chu CH; Chin LT; Chen HM
    J Immunol Methods; 2010 Sep; 361(1-2):89-97. PubMed ID: 20723546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.